Class 3 Medicines Recall: Digoxin Tablets BP 250 micrograms (Accord-Uk Limited)
Class 3 Medicines Recall: Digoxin Tablets BP 250 micrograms (Accord-Uk Limited)
August 3, 2020
Class 3 Medicines recall: Digoxin Tablets BP 250 micrograms (Accord-Uk Limited) PL 0142/0083
Drug alert number: EL (20) A/35
Date issued: 03 August 2020
The Medicines and Health products Regulatory Agency (MHRA) has issued a class 3 medicines recall for:
Irinotecan Hydrochloride Concentrate for Solution for Digoxin Tablets BP 250 micrograms (Accord-Uk Limited) PL 0142/0083
Accord-UK Ltd has informed MHRA of an issue related to decommissioning of the batch listed below. Upon decommissioning at the pharmacy, there have been reports stating that when scanning the serialised 2D code, the status of packs may report as ‘EXPORT.’ Although there is no risk to product quality, any remaining stock should be quarantined and returned.
Digoxin Tablets BP 250 micrograms (Accord-Uk Limited) PL 0142/0083
| Batch Number | Expiry Date | Pack Size | First Distributed |
| XDG396 | 11/2021 | 28 | 26/03/2019 |
Advice for Healthcare Professionals
Quarantine all remaining stock and return it to your supplier using your supplier’s approved process.
Company contacts for further information
For stock control enquiries please contact Accord-UK Ltd Customer Services Team on 0800 373573.
For medical information enquiries please contact Accord-UK Ltd Medical Information Department on 01271 385257.
View the full alert here.
Posted in: Dispensing & Supply, PSNC News
